Skip to main content
DVA
NYSE Life Sciences

DaVita and Humana Launch Value-Based Care for 10,000+ CKD Patients

Tom Rudovsky · Reported by PR Newswire
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$176.5
Mkt Cap
$11.261B
52W Low
$101
52W High
$247.49
52W Position info
75% above low
Off High info
29% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

DVA sits 75% above its 52-week low of $101.

Summary

DaVita announced a new value-based care agreement with Humana to manage Medicare Advantage members with chronic kidney disease stages 3B-5. The program, launched July 1, will serve more than 10,000 patients and aims to delay or prevent dialysis and reduce hospitalizations. This expands DaVita's existing collaboration with Humana in end-stage kidney disease into earlier disease stages, leveraging its network of 3,000 value-based nephrologist partners. The partnership aligns with DaVita's strategy to grow its integrated kidney care business and could improve patient outcomes while creating a new revenue stream. No financial terms were disclosed, but the scale of the patient population suggests a meaningful expansion of DaVita's value-based care footprint.

At the time of this announcement, DVA was trading at $176.50 on NYSE in the Life Sciences sector, with a market capitalization of approximately $11.3B. The 52-week trading range was $101.00 to $247.49. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

DVA - Latest Insights

DVA
Nov 10, 2026, 12:42 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $180.24
Real-time Price: $172.29 info
Change: -$7.95 (-4%) info
Market Cap: $10.877B info
DVA
Oct 29, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $180.00
Real-time Price: $172.29 info
Change: -$7.71 (-4%) info
Market Cap: $10.877B info
DVA
Oct 29, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $184.00
Real-time Price: $172.29 info
Change: -$11.71 (-6%) info
Market Cap: $10.877B info
DVA
Oct 29, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $193.31
Real-time Price: $172.29 info
Change: -$21.02 (-11%) info
Market Cap: $10.877B info
DVA
Sep 04, 2026, 10:56 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $182.70
Real-time Price: $172.29 info
Change: -$10.41 (-6%) info
Market Cap: $10.877B info